Published in Clin Pharmacol Ther on September 01, 2003
A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth (2004) 1.15
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era. Cancer Prev Res (Phila) (2009) 0.99
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer (2012) 0.91
Folic acid and human reproduction-ten important issues for clinicians. J Exp Clin Assist Reprod (2011) 0.90
Childhood cancer incidence trends in association with US folic acid fortification (1986-2008). Pediatrics (2012) 0.90
Childhood cancer among twins and higher order multiples. Cancer Epidemiol Biomarkers Prev (2009) 0.89
Molecular mechanisms underlying the potentially adverse effects of folate. Clin Chem Lab Med (2013) 0.89
Folate during reproduction: the Canadian experience with folic acid fortification. Nutr Res Pract (2007) 0.88
Folic acid supplementation in pregnancy and implications in health and disease. J Biomed Sci (2014) 0.84
Case control study of periconceptional folic acid intake and nervous system tumors in children. Childs Nerv Syst (2010) 0.83
Maternal B vitamin supplementation from preconception through weaning suppresses intestinal tumorigenesis in Apc1638N mouse offspring. Gut (2011) 0.81
High Folic Acid Intake during Pregnancy Lowers Body Weight and Reduces Femoral Area and Strength in Female Rat Offspring. J Osteoporos (2013) 0.80
Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands. BMC Pregnancy Childbirth (2014) 0.80
RFC-1 80G>A polymorphism in case-mother/control-mother dyads is associated with risk of nephroblastoma and neuroblastoma. Genet Test Mol Biomarkers (2014) 0.77
Folic Acid Supplementation for Women of Childbearing Age versus Supplementation for the General Population: A Review of the Known Advantages and Risks. Int J Family Med (2011) 0.76
Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group. Br J Cancer (2010) 0.76
Temporal clustering of neuroblastic tumours in children and young adults from Northern England. Environ Health (2015) 0.75
General paediatric research: Abstract summaries and commentaries. Paediatr Child Health (2004) 0.75
Gene promoter DNA methylation patterns have a limited role in orchestrating transcriptional changes in the fetal liver in response to maternal folate depletion during pregnancy. Mol Nutr Food Res (2016) 0.75
Might salicylate exert benefits against childhood cancer? Ecancermedicalscience (2010) 0.75
Multivitamin supplements for pregnant women. New insights. Can Fam Physician (2004) 0.75
Supplemental folic acid in pregnancy and childhood cancer risk. Br J Cancer (2016) 0.75
Folic acid and neuroblastoma: too soon to tell. Clin Pharmacol Ther (2004) 0.75
Pediatric cancer epigenome and the influence of folate. Epigenomics (2015) 0.75
Organ-Specific Gene Expression Changes in the Fetal Liver and Placenta in Response to Maternal Folate Depletion. Nutrients (2016) 0.75
The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies. J Cancer (2016) 0.75
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84
Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA (2009) 6.06
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
How I treat hemophagocytic lymphohistiocytosis. Blood (2011) 5.08
Emergency department computed tomography utilization in the United States and Canada. Ann Emerg Med (2013) 4.81
PROSPER community-university partnership model for public education systems: capacity-building for evidence-based, competence-building prevention. Prev Sci (2004) 4.01
Screening of infants and mortality due to neuroblastoma. N Engl J Med (2002) 4.00
Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology (2003) 3.83
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68
The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*. Crit Care Med (2014) 3.29
The risk of missed diagnosis of acute myocardial infarction associated with emergency department volume. Ann Emerg Med (2006) 3.29
Ultrasound imaging for lumbar punctures and epidural catheterisations: systematic review and meta-analysis. BMJ (2013) 3.02
Substance-use outcomes at 18 months past baseline: the PROSPER Community-University Partnership Trial. Am J Prev Med (2007) 2.96
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86
Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86
Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ (2004) 2.81
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet (2005) 2.76
Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64
Bias in published cost effectiveness studies: systematic review. BMJ (2006) 2.60
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol (2012) 2.59
Preventive interventions addressing underage drinking: state of the evidence and steps toward public health impact. Pediatrics (2008) 2.53
Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53
Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood (2013) 2.46
Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int (2013) 2.42
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood (2012) 2.39
Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA (2002) 2.37
Proliferation of prenatal ultrasonography. CMAJ (2010) 2.33
Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32
Toward dissemination of evidence-based family interventions: maintenance of community-based partnership recruitment results and associated factors. J Fam Psychol (2007) 2.27
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23
Derivation of a termination-of-resuscitation guideline for emergency medical technicians using automated external defibrillators. Acad Emerg Med (2002) 2.22
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol (2006) 2.19
Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int (2004) 2.09
Langerhans cell histiocytosis: Current concepts and treatments. Cancer Treat Rev (2010) 2.07
Association of neural tube defects and folic acid food fortification in Canada. Lancet (2002) 2.07
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04
PROSPER STUDY OF EVIDENCE-BASED INTERVENTION IMPLEMENTATION QUALITY BY COMMUNITY-UNIVERSITY PARTNERSHIPS. J Community Psychol (2007) 2.03
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03
FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01
Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology (2007) 2.00
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98
A systematic review of faces scales for the self-report of pain intensity in children. Pediatrics (2010) 1.96
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ (2010) 1.95
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke (2009) 1.94
Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93
Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91
Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2014) 1.81
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80
Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531. J Clin Oncol (2014) 1.79
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78
Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78
Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77
Prevention of venous thromboembolism. Chest (2005) 1.76
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76
Hospital and home chemotherapy for children with leukemia: a randomized cross-over study. Pediatr Blood Cancer (2006) 1.72
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70
Preeclampsia as a risk factor for diabetes: a population-based cohort study. PLoS Med (2013) 1.69
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2013) 1.69
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry (2002) 1.68
Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65
Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65
Preventing substance misuse through community-university partnerships: randomized controlled trial outcomes 4½ years past baseline. Am J Prev Med (2011) 1.63
More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63
Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62
Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62
Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60
Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60
Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer (2012) 1.60
Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis. J Natl Cancer Inst (2004) 1.59
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58
Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57
Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55
Imaging in pediatric patients: time to think again about surveillance. Pediatr Blood Cancer (2010) 1.52
Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52
Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50
Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer (2009) 1.49
Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48
Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol (2008) 1.44
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Disequilibrium between admitted and discharged hospitalized patients affects emergency department length of stay. Ann Emerg Med (2009) 1.44